St. Jude found 156 potential targets for chimeric antigen receptor (CAR) T–cell immunotherapy. Explore the discovery’s promise to improve cancer therapies. (IMAGE)

St. Jude Children's Research Hospital

St. Jude found 156 potential targets for chimeric antigen receptor (CAR) T–cell immunotherapy. Explore the discovery’s promise to improve cancer therapies.

Caption

Artistic rendering of a chimeric antigen receptor (CAR) (blue) on a T cell attaching to a targeted cancer protein (red) on another cell.

Credit

St. Jude Children's Research Hospital

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.